Loading...
XTSE
VNP
Market cap2.55bUSD
Jul 09, Last price  
40.46CAD
1D
0.52%
1Q
14.07%
Jan 2017
2,160.34%
IPO
461.94%
Name

5N Plus Inc

Chart & Performance

D1W1MN
XTSE:VNP chart
P/E
49.91
P/S
6.45
EPS
0.57
Div Yield, %
Shrs. gr., 5y
1.77%
Rev. gr., 5y
17.56%
Revenues
398m
+37.55%
12,533,94331,150,49863,645,06167,066,632183,065,9770551,675,000459,012,000508,195,000311,012,000231,498,000219,916,000217,995,000195,971,000177,192,000209,990,000264,223,000242,371,000289,281,000397,907,748
Net income
51m
+250.68%
697,3477,810,65719,145,06713,882,34522,153,8610-227,738,00042,661,00010,812,000-97,198,000-5,895,00012,023,00013,972,0001,785,0002,186,0003,110,000-22,999,00015,399,00014,672,00051,451,184
CFO
69m
P
0014,898,75615,949,1810101,812,00047,963,000-17,173,00064,009,00023,464,00013,110,0002,195,0002,681,00036,805,00010,270,00023,741,00018,974,000-6,886,00068,569,697

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

5N Plus Inc. specializes in the production and global distribution of advanced semiconductor materials, spanning North America, Europe, and Asia. Its operations are strategically divided into two core segments: Specialty Semiconductors and Performance Materials. The company's comprehensive product portfolio encompasses low melting point alloys, semiconductor compounds and wafers, as well as a variety of specialized chemicals and metals. The firm also manufactures high-purity metallic powders essential for micro-electronic and advanced manufacturing processes. Furthermore, the company's scope extends to producing animal feed additives and pharmaceutical ingredients, complemented by offering material recycling solutions. These materials and services cater to a diverse array of critical applications, including but not limited to, renewable energy, security, aerospace, pharmaceuticals, medical imaging, general manufacturing, electronics, consumer products, and various industrial sectors. 5N Plus Inc. is headquartered in Montreal, Canada.
IPO date
Dec 20, 2007
Employees
766
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT